Education
About Us
Working with TipRanks
Follow Us
Novolog (Pharm UP 1966) Ltd. (IL:NVLG)
:NVLG
NVLG Stock Chart & Stats
Day’s Range― - ―
52-Week Range131.13 - 196.00
Previous CloseN/A
Volume351.22K
Average Volume (3M)335.67K
Market Cap
701.90M
Enterprise Value1.45B
Total Cash (Recent Filing)247.60M
Total Debt (Recent Filing)198.47M
Price to Earnings (P/E)24.6
Beta0.80
Next Earnings
Aug 19, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 02, 2024Dividend Yield5.7%
Share Statistics
EPS (TTM)0.20
Shares Outstanding510,842,470
10 Day Avg. Volume526,386
30 Day Avg. Volume335,674
Financial Highlights & Ratios
PEG Ratio2.48
Price to Book (P/B)3.22
Price to Sales (P/S)0.00
P/FCF Ratio22.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Novolog News
PremiumCompany Announcements
Novolog Updates Securities Registry Amid Strategic Option Exercises
PremiumCompany Announcements
Novolog Announces Major Change in Securities Holdings
PremiumCompany Announcements
Novolog Announces Dividend Distribution for Shareholders
PremiumCompany Announcements
Novolog Approves New Terms for Chairman’s Employment
PremiumCompany Announcements
Novolog Announces Extraordinary General Meeting to Discuss Subsidiary Merger
PremiumCompany Announcements
Pharm-Up 1966 Ltd. Announces Annual and Special General MeetingNVLG FAQ
What was Novolog (Pharm UP 1966) Ltd.’s price range in the past 12 months?
Novolog (Pharm UP 1966) Ltd. lowest stock price was 131.13 and its highest was 196.00 in the past 12 months.
What is Novolog (Pharm UP 1966) Ltd.’s market cap?
Novolog (Pharm UP 1966) Ltd.’s market cap is 701.90M.
When is Novolog (Pharm UP 1966) Ltd.’s upcoming earnings report date?
Novolog (Pharm UP 1966) Ltd.’s upcoming earnings report date is Aug 19, 2025 which is in 42 days.
How were Novolog (Pharm UP 1966) Ltd.’s earnings last quarter?
Novolog (Pharm UP 1966) Ltd. released its earnings results on May 20, 2025. The company reported 0.2 earnings per share for the quarter, beating the consensus estimate of N/A by 0.2.
Is Novolog (Pharm UP 1966) Ltd. overvalued?
According to Wall Street analysts Novolog (Pharm UP 1966) Ltd.’s price is currently Overvalued.
Does Novolog (Pharm UP 1966) Ltd. pay dividends?
Novolog (Pharm UP 1966) Ltd. pays a Quarterly dividend of 1.958 which represents an annual dividend yield of 5.7%. See more information on Novolog (Pharm UP 1966) Ltd. dividends here
What is Novolog (Pharm UP 1966) Ltd.’s EPS estimate?
Novolog (Pharm UP 1966) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novolog (Pharm UP 1966) Ltd. have?
Novolog (Pharm UP 1966) Ltd. has 510,842,470 shares outstanding.
What happened to Novolog (Pharm UP 1966) Ltd.’s price movement after its last earnings report?
Novolog (Pharm UP 1966) Ltd. reported an EPS of 0.2 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.544%.
Which hedge fund is a major shareholder of Novolog (Pharm UP 1966) Ltd.?
Currently, no hedge funds are holding shares in IL:NVLG
Company Description
Novolog (Pharm UP 1966) Ltd.
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. It offers medical devices to healthcare institutions and patients in their homes; and medical logistics services to pharmaceutical and medical device companies. The company also produces and disseminates medical content and tools to the general public and medical community; and develops personalized treatment programs and initiates home visits by nurses. In addition, it provides health and medical process management services for corporations; and supplies sterilization services using ethylene oxide gas for medical and laboratory products, as well as offers direct access to health and wellness ecosystem for international corporations. The company is based in Modi'in-Maccabim-Re'ut, Israel.